Eighty pediatric patients with congenital heart disease undergoing cardiac surgery with CPB were randomized to receive either 10-20 ml/kg 4 % succinylated gelatin ( Gelofusine , GEL group , n = 40 ) or 1-2 units FFP ( FFP group , n = 40 ) in the pump prime .